tegafur has been researched along with Atypical Ductal Hyperplasia in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective randomized study was performed in 22 institutions from July 1978, to evaluate the efficiency of long-term adjuvant chemotherapy with tegafur alone for primary breast cancer." | 9.06 | [Cooperative study of postoperative long-term adjuvant therapy of breast cancer. First study of a series--comparative study between postoperative tegafur administration and no adjuvant chemotherapy]. ( Iwasa, Z; Kawahara, T; Kousaki, G; Okajima, K; Okamoto, E; Sakai, K; Senoo, T; Taguchi, T; Terasawa, T; Utsunomiya, J, 1988) |
| "A prospective randomized study was performed in 22 institutions from July 1978, to evaluate the efficiency of long-term adjuvant chemotherapy with tegafur alone for primary breast cancer." | 5.06 | [Cooperative study of postoperative long-term adjuvant therapy of breast cancer. First study of a series--comparative study between postoperative tegafur administration and no adjuvant chemotherapy]. ( Iwasa, Z; Kawahara, T; Kousaki, G; Okajima, K; Okamoto, E; Sakai, K; Senoo, T; Taguchi, T; Terasawa, T; Utsunomiya, J, 1988) |
| "Tamoxifen and UFT were administered as chemoendocrine therapy." | 1.28 | [A case of brain metastasis from breast cancer responding to chemoendocrine therapy]. ( Abe, R; Honda, K; Kanazawa, M; Nomizu, T; Tsuchiya, A; Watanabe, F; Yamaki, Y, 1990) |
| "In 41 cases of primary breast cancer preoperative treatment was performed using 2 methods consisting CPA + FT-207 (5-FUDS) (for Group I) and CPA + FT-207 (5-FUDS) + MMC (for Group II) to determine clinical and histological efficacies." | 1.27 | [Clinical study on preoperative chemotherapy of primary breast cancer. 2--A comparative study of CPA + FT-207 (5-FUDS) and CPA + FT-207 (5-FUDS) + MMC]. ( Andoh, H; Fujii, Y; Gotoh, M; Hagiwara, H; Hara, Y; Kataoka, J; Kobayashi, T; Komuro, K; Nagasaki, Y; Nagayama, A; Nakamura, K; Nakamura, R, 1983) |
| "One partial remission out of 7 cases of stomach cancer was obtained, and its duration was 40 weeks." | 1.27 | [Clinical trial on the effect of tegafur (SF-SP)]. ( Akazawa, S; Futatsuki, K; Hattori, M; Ishibashi, I; Kanda, Y; Sendai, H; Shimada, S, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komuro, K | 1 |
| Hara, Y | 1 |
| Fujii, Y | 1 |
| Nagayama, A | 1 |
| Kobayashi, T | 1 |
| Gotoh, M | 1 |
| Hagiwara, H | 1 |
| Nakamura, R | 1 |
| Nagasaki, Y | 1 |
| Kataoka, J | 1 |
| Andoh, H | 1 |
| Nakamura, K | 1 |
| Ohyama, K | 2 |
| Koike, D | 1 |
| Odake, Y | 1 |
| Takiyama, Y | 1 |
| Saitoh, T | 1 |
| Kagaya, T | 1 |
| Takebe, T | 1 |
| Ishii, K | 1 |
| Futatsuki, K | 1 |
| Shimada, S | 1 |
| Kanda, Y | 1 |
| Ishibashi, I | 1 |
| Sendai, H | 1 |
| Akazawa, S | 1 |
| Hattori, M | 1 |
| Nomizu, T | 1 |
| Watanabe, F | 1 |
| Honda, K | 1 |
| Kanazawa, M | 1 |
| Yamaki, Y | 1 |
| Tsuchiya, A | 1 |
| Abe, R | 1 |
| Terasawa, T | 1 |
| Kousaki, G | 1 |
| Sakai, K | 1 |
| Senoo, T | 1 |
| Taguchi, T | 1 |
| Iwasa, Z | 1 |
| Utsunomiya, J | 1 |
| Okajima, K | 1 |
| Okamoto, E | 1 |
| Kawahara, T | 1 |
1 trial available for tegafur and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
[Cooperative study of postoperative long-term adjuvant therapy of breast cancer. First study of a series--comparative study between postoperative tegafur administration and no adjuvant chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltr | 1988 |
5 other studies available for tegafur and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
[Clinical study on preoperative chemotherapy of primary breast cancer. 2--A comparative study of CPA + FT-207 (5-FUDS) and CPA + FT-207 (5-FUDS) + MMC].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; | 1983 |
[Antineoplastic effect of UFT therapy (uracil-FT-207 combination therapy) on experimental pancreatic cancer transplanted in the pancreas and subcutaneous region].
Topics: Animals; Antineoplastic Agents; Carcinoma, Intraductal, Noninfiltrating; Cricetinae; Drug Therapy, C | 1982 |
[Clinical trial on the effect of tegafur (SF-SP)].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Capsules; Carcinoma, Intraductal, Noninfiltrating | 1984 |
[A case of brain metastasis from breast cancer responding to chemoendocrine therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, | 1990 |
[Effects of anti-tumor drugs and gastrointestinal hormones on the growth of pancreatic duct cell adenocarcinoma in homologous transplanted animal models].
Topics: Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Intraductal, Noninfiltrating; Cricetinae; Ga | 1985 |